In theory, you could drive Toyota’s 2010 Prius from Montreal to Toronto on about 16 liters of gas.

A turbo-boosted in-line-four directs a considerable load of torque in this baby.

Fun-to-drive handling combines with front-wheel or all-wheel-drive traction.

Exclusivity, engineering and design make these six-figure vehicles special.

These rally cars and posh sedans offer the power of a sports car with the space of a wagon.

Mercedes will put a zero-emissions version of the SLS supercar into production.

Surprising new survey: Why most of us would buy a green car over our dream car.

Innovators and scientists on the front lines of fuel development are finding algae a potential gold mine.

Volkswagen’s new green concepts may change the way we view green autos.

Check out the hot new cars rolled out in Frankfurt.

Cars showcased at Frankfurt celebrate innovation.

A look at some of the hottest open-topped vehicles on the market.

GPS could play a vital role in accident prevention by allowing a satellite to help with things like traction control.

Mercedes will put a zero-emissions version of the SLS supercar into production.

Head collision prevention airbags are close to production.

Want to avoid those pesky speeding tickets? Questions every driver should ask when nabbed for speeding.

These sedans, wagons and SUVs are your best bet for navigating Old Man Winter.

Institute weighs in with surprising verdict on crash prevention technology.

DUSA Pharmaceuticals, Inc.(®) (Nasdaq GM: DUSA), a dermatology company that is developing and marketing Levulan(®) Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Merriman Curhan Ford Investor Summit 2009 on Tuesday, November 10, 2009 at 10:00 a.m. ET at the Hotel Sofitel in New York City.

Helix BioPharma Corp. (TSX, FSE: "HBP" / Pink Sheets: HXBPF) today announced that John Docherty, president and chief operating officer, will present at Merriman Curhan Ford's 6th annual Investor Summit on November 10, 2009 at 4:00 PM at the Sofitel Hotel in New York City.

Helix BioPharma Corp. (TSX, FSE: "HBP" / Pink Sheets: HXBPF) today announced that John Docherty, president and chief operating officer, will present at Merriman Curhan Ford's 6th annual Investor Summit on November 10, 2009 at 4:00 PM at the Sofitel Hotel in New York City.